Bone Biologics Corporation develops medical devices for bone regeneration in spinal fusion using recombinant human protein. Their NELL-1/DBX product offers specific control over bone regeneration, and they are currently developing a Fusion Device for spinal fusion procedures. Their technology has a variety of applications in surgical specialties and is developed in partnership with UCLA.